Jawad Ul Karim Mahir

Mr. Jawad Ul Karim Mahir

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2025 in Medical Sciences
Verified
Journal Article
Open access
SSShakila Jahan Shimu
Shakila Jahan Shimu
Jawad Ul Karim MahirJawad Ul Karim Mahir
Jawad Ul Karim Mahir
FSFardin Al Fahad Shakib
Fardin Al Fahad Shakib
ARArafath Amin Ridoy
Arafath Amin Ridoy
RSRatin Al Samir
Ratin Al Samir
MUMOHAMMAD BORHAN UDDIN
MOHAMMAD BORHAN UDDIN
Obesity-induced insulin resistance and type 2 diabetes mellitus (T2DM) represent complex systemic disorders marked by chronic inflammation, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress. These pathophysiological processes disrupt insulin signaling and β-cell function, leading to impaired glucose homeostasis across multiple organs. Conventional therapies often target isolated pathways, overlooking the intricate molecular crosstalk and organelle-level disturbances driving disease progression. Citrus-derived polyphenols—including hesperidin, naringenin, nobiletin, and tangeretin—have emerged as promising agents capable of orchestrating a multi-targeted “metabolic reprogramming.” These compounds modulate key signaling pathways, including AMPK, PI3K/Akt, NF-κB, and Nrf2, thereby enhancing insulin sensitivity, reducing pro-inflammatory cytokine expression, and restoring redox balance. Furthermore, they improve mitochondrial biogenesis, stabilize membrane potential, and alleviate ER stress by modulating the unfolded protein response (UPR), thus supporting cellular energy homeostasis and protein folding capacity. Evidence from preclinical studies and select clinical trials suggests that citrus polyphenols can significantly improve glycemic control, reduce oxidative and inflammatory markers, and preserve β-cell function. Their pleiotropic actions across molecular and organ-level targets position them as integrative metabolic modulators. This review presents a systems-level synthesis of how citrus polyphenols rewire metabolic signaling networks and organelle resilience, offering a holistic therapeutic strategy to mitigate the root causes of obesity-induced insulin resistance.

7 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SSShakila Jahan Shimu
Shakila Jahan Shimu
Jawad Ul Karim MahirJawad Ul Karim Mahir
Jawad Ul Karim Mahir
FSFardin Al Fahad Shakib
Fardin Al Fahad Shakib
ARArafath Amin Ridoy
Arafath Amin Ridoy
RSRatin Al Samir
Ratin Al Samir
MUMOHAMMAD BORHAN UDDIN
MOHAMMAD BORHAN UDDIN
Obesity-induced insulin resistance and type 2 diabetes mellitus (T2DM) represent complex systemic disorders marked by chronic inflammation, oxidative stress, mito-chondrial dysfunction, and endoplasmic reticulum (ER) stress. These pathophysiologi-cal processes disrupt insulin signaling and β-cell function, leading to impaired glucose homeostasis across multiple organs. Conventional therapies often target isolated pathways, overlooking the intricate molecular crosstalk and organelle-level disturb-ances driving disease progression. Citrus-derived polyphenols—including hesperidin, naringenin, nobiletin, and tange-retin have emerged as promising agents capable of orchestrating a multi-targeted “metabolic reprogramming.” These compounds modulate key signaling pathways, in-cluding AMPK, PI3K/Akt, NF-κB, and Nrf2, thereby enhancing insulin sensitivity, re-ducing pro-inflammatory cytokine expression, and restoring redox balance. Further-more, they improve mitochondrial biogenesis, stabilize membrane potential, and alle-viate ER stress by modulating the unfolded protein response (UPR), thus supporting cellular energy homeostasis and protein folding capacity. Evidence from preclinical studies and select clinical trials suggests that citrus poly-phenols can significantly improve glycemic control, reduce oxidative and inflamma-tory markers, and preserve β-cell function. Their pleiotropic actions across molecular and organ-level targets position them as integrative metabolic modulators. This review presents a systems-level synthesis of how citrus polyphenols rewire metabolic signal-ing networks and organelle resilience, offering a holistic therapeutic strategy to miti-gate the root causes of obesity-induced insulin resistance.

18 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MHMahmudul Hoque
Mahmudul Hoque
Shamima AkterShamima Akter
Shamima Akter
Mayank ChoubeyMayank Choubey
Mayank Choubey
Jawad Ul Karim MahirJawad Ul Karim Mahir
Jawad Ul Karim Mahir
NANadia Afrin
Nadia Afrin
MUMOHAMMAD BORHAN UDDIN
MOHAMMAD BORHAN UDDIN
Diabetes mellitus casts a long shadow over the nervous system, driving a spectrum of complications that extend far beyond glycemic control. Diabetic peripheral neuropathy and diabetes-associated cognitive decline—long viewed as separate clinical entities—are now recognized as intertwined expressions of a multi-organ, multi-pathway disease process. At the molecular core, hyperglycemia, oxidative stress, mitochondrial injury, immune activation, and vascular dysfunction con-verge with insulin resistance to erode neuronal and glial integrity. These events are amplified by gut dysbiosis, which reshapes immune tone, dis-rupts neurovascular homeostasis, and fuels neurodegeneration via the gut–brain–nerve axis. Recent advances reveal that neuroinflammation, microvascular rare-faction, metabolic inflexibility, and lipid-mediated toxicity act not in isolation but as a self-reinforcing network linking peripheral and central injury. Yet, progress toward disease-modifying therapy remains slow, hindered by knowledge gaps in longitudinal human phenotyping, incomplete animal models, underdeveloped biomarkers, and neglected dimensions such as epigenetic memory, circadian disruption, and sex-specific biology. This Review integrates emerging mechanistic insights—from endothelial dys-function and mitochondrial permeability transition to short-chain fatty acid sig-naling and ceramide neurotoxicity—with an urgent call for precision medicine approaches. By aligning metabolic, vascular, immune, and microbial interventions within longitudinal, biomarker-driven frameworks, the field stands poised to shift from symptom management to strategies that can slow, halt, or even reverse the neurological toll of diabetes.